Literature DB >> 6796943

Mode of degradation of tRNAs with ozone.

N Shinriki, K Ishizaki, A Ikehata, K Miura, T Ueda, N Kato, F Harada.   

Abstract

Ozone-treatment of tRNA resulted in the degradation of guanine residues located on the loop regions, such as the anticodon and D-loop region. In addition, it became evident that the guanine residues in the consecutive sequences, such as G-G-G-G and G-G-m1G in tRNAPro, were the most susceptive to the ozone-treatment. The internucleotidic linkage of the treated tRNA was not cleaved but several fragments were obtained by a gel electrophoretic separation after heating at 60% in 1M aniline-acetate buffer (pH 4.5). Major fragments derived from tRNAPro were the 3'-half and the 5'-half molecules produced by the cleavage at the anticodon region.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6796943

Source DB:  PubMed          Journal:  Nucleic Acids Symp Ser        ISSN: 0261-3166


  4 in total

1.  A previously unidentified activity of yeast and mouse RNA:pseudouridine synthases 1 (Pus1p) on tRNAs.

Authors:  Isabelle Behm-Ansmant; Séverine Massenet; Françoise Immel; Jeffrey R Patton; Yuri Motorin; Christiane Branlant
Journal:  RNA       Date:  2006-06-27       Impact factor: 4.942

2.  Host cell reactivation capacity of different strains of E. coli B resistant or sensitive to ozone.

Authors:  P L'Hérault; Y S Chung
Journal:  Experientia       Date:  1984-07-15

3.  TFIIIR is an isoleucine tRNA.

Authors:  H M Dunstan; L S Young; K U Sprague
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

4.  Pseudouridine synthase 1 deficient mice, a model for Mitochondrial Myopathy with Sideroblastic Anemia, exhibit muscle morphology and physiology alterations.

Authors:  Joshua E Mangum; Justin P Hardee; Dennis K Fix; Melissa J Puppa; Johnathon Elkes; Diego Altomare; Yelena Bykhovskaya; Dean R Campagna; Paul J Schmidt; Anoop K Sendamarai; Hart G W Lidov; Shayne C Barlow; Nathan Fischel-Ghodsian; Mark D Fleming; James A Carson; Jeffrey R Patton
Journal:  Sci Rep       Date:  2016-05-20       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.